Introduction
Disulfide bonds play a key role in the folding pathway of many proteins and cells have evolved complex machineries to promote disulfide catalysis. In the periplasmic space of Gram-negative bacteria, the disulfide-bond (Dsb) proteins regulate the formation and rearrangement of disulfide bonds during protein folding (Kadokura et al., 2003; Masip et al., 2004) . Escherichia coli Dsb proteins form two pathways, the DsbA-DsbB pathway (Bardwell et al., 1991 , which rapidly introduces disulfide bonds into target proteins, and the DsbC/DsbG-DsbD pathway (Rietsch et al., 1996) , which catalyses the rearrangement of incorrect disulfide bonds.
Protein disulfide catalysis has been studied extensively in E. coli, but little information is available about this process in other organisms. For example, Gram-positive bacteria do not have a classic periplasmic compartment, but do contain an extraprotoplasmic compartment confined between the plasma membrane and the outer cell wall (Pooley et al., 1996; Matias & Beveridge, 2006) , and genomic sequence data indicates that they encode Dsb orthologues (Kouwen et al., 2007) . Moreover, functional Dsb homologues have been described in Gram-positive organisms, including Bacillus brevis (Ishihara et al., 1995) , B. subtilis (Erlendsson & Hederstedt, 2002; Dorenbos et al., 2002; Sarvas et al., 2004; Meima et al., 2002; Stein, 2005) and Mycobacterium tuberculosis (Goulding et al., 2004) . However, the mechanisms of disulfide catalysis in Gram-positive bacteria remain mostly uncharacterized.
To investigate the oxidative folding of secreted proteins in Grampositive bacteria, we focused on Staphylococcus aureus, a human pathogen that secretes disulfide-bond-containing virulence factors (Dziewanowska et al., 1996) . This organism encodes a DsbA homologue (SaDsbA), a 23 kDa lipoprotein that shares just 15% sequence identity with E. coli DsbA yet can functionally complement this protein (Dumoulin et al., 2005) . Here, we report the crystallization of SaDsbA, which to the best of our knowledge is the first Grampositive DsbA to be crystallized.
Material and methods

Cloning, expression and protein purification
To prepare SaDsbA (AAG41993) for crystallization, a gene fragment encoding a soluble form of the protein (residues 6-181 of the mature protein; Dumoulin et al., 2005) was cloned into a pET21a vector (Novagen) using NheI and XhoI restriction sites. The cloning procedure introduced four additional residues: two at the N-terminus (Met-Ala) and two at the C-terminus (Leu-Glu). SaDsbA engineered with a C-terminal hexahistidine tag was expressed in BL21 (DE3) pLysS cells using autoinduction (Studier, 2005) . Briefly, cells harbouring pET21a-SaDsbA were grown with agitation at 200 rev min À1 for 24 h at 303 K in minimal medium (Studier, 2005) supplemented with 100 mg ml À1 ampicillin. The cells were then harvested by centrifugation and lysed in 50 mM Tris pH 7, 150 mM NaCl, 0.5% Triton-X, EDTA-free protease-inhibitor cocktail (Roche) and DNase. Cell debris was removed by centrifugation at 21 000g for 30 min. Histidine-tagged SaDsbA was purified using cobalt-chelate chromatography (BD TALON resin) and eluted with 50 mM Tris pH 7, 150 mM NaCl, 250 mM imidazole.
SaDsbA was oxidized by the addition of 1.7 mM copper(II) 1,10-phenanthroline (1 h, 277 K) and then equilibrated in 25 mM 4-(2-hydroxyethyl)-1-piperazine-N-2-ethanesulfonic acid (HEPES) pH 6.7, 150 mM NaCl using a PD-10 column (GE Healthcare). The protein was further purified by gel-filtration chromatography (Ä KTA, GE Healthcare, Piscataway, NJ, USA) using a Superdex S-200 column (GE Healthcare, Piscataway, NJ, USA) followed by ion-exchange chromatography on a Mono S 5/50GL column (GE Healthcare, Piscataway, NJ, USA).
Fractions containing SaDsbA were pooled and concentrated to 50 mg ml À1 in 20 mM HEPES buffer pH 6.7, 50 mM NaCl using Amicon Ultra centrifugal filter devices with 10 kDa cutoff (Millipore, Billerica, MA, USA). The protein concentration was measured at 280 nm (NanoDrop ND-1000, NanoDrop Technologies, Wilmington, DE, USA) and the purity was assessed by SDS-PAGE analysis and mass spectrometry.
LC/MS analysis of SaDsbA was undertaken using an Applied Biosystems/MDS SCIEX QSTAR Pulsar electrospray ionization quadrupole time-of-flight (ESI QqTOF) mass spectrometer equipped with an electrospray ionization source and linked to an upstream Agilent 1100 Series HPLC system. Selenomethionine (SeMet) SaDsbA was produced using previously described methods (Heras et al., 2003) . Briefly, BL21(DE3) pLysS cells harbouring pET21a-SaDsbA plasmid were grown at 310 K in M63 minimal medium containing 50 mg ml À1 dl-selenomethionine. Cultures were induced with 0.5 mM IPTG (final concentration) and harvested 3 h post-induction. SeMet SaDsbA was extracted and purified as described above for native SaDsbA.
Crystallization and diffraction data measurement
Initial crystallization trials were carried out using the sitting-drop vapour-diffusion method in 96-well plates (Greiner low profile with one and three drops per well) and commercial crystallization screens including Crystal Screens I and II, PEG/Ion Screen, Sodium Malonate Grid Screen (Hampton Research, San Diego, CA, USA), JB Screen 2, JB Screen 3, Precipitant Synergy Screen and Wizard I and II (Jena Bioscience, Jena, Germany). The sitting-drop crystallization trials were set up manually using a multi-channel pipette (Matrix Impact, Thermo Fisher Scientific, Waltham, MA, USA); 1 ml protein solution (50 mg ml À1 in 25 mM HEPES pH 6.7, 50 mM NaCl) and 1 ml precipitant solution were added together and then equilibrated against well solution (100 ml) in a temperature-controlled room at 293 K. The sitting-drop crystallization trials ($800) failed to produce crystals. Further trials were carried out using a TOPAZ FID Crystallizer (TOPAZ Screening Chip 1.96) and OptiMix-1 and OptiMix-2 screens (Fluidigm Corporation, San Francisco, CA, USA). This system requires just 1 ml of protein to screen 96 conditions. Using this free-interface diffusion approach, crystals were observed in a condition containing only 25% polyethylene glycol of average molecular weight 3350 Da (PEG 3350). This condition was translated following the manufacturer's recommended procedure to 24-well hanging-drop vapour-diffusion experiments using VDXm plates and 18 mm siliconized cover slips (Hampton Research, San Diego, CA, USA). Higher concentrations of PEG 3350 were screened (25-35% PEG 3350 in water) and three different protein:precipitant ratios (1 ml:1 ml, 0.75 ml:1.25 ml and 0.5 ml:1.5 ml). The protein concentration used in the optimization screens was 50 mg ml À1 in 25 mM HEPES pH 6.7, 50 mM NaCl. Crystals of SeMet SaDsbA were grown essentially as described for the native protein.
X-ray diffraction
Diffraction data for native SaDsbA crystals were measured using a Rigaku FR-E copper rotating-anode generator operated at 45 kV and 45 mA with Osmic Confocal Max-Flux optics (either HiRes 2 or Maxscreen; Rigaku Americas, Houston, TX, USA). Reflections were measured with an R-AXIS IV ++ imaging-plate area detector (Rigaku Americas, Houston, TX, USA). A Cryo Industries CryoCool LN2 (Cryo Industries, Manchester, NH, USA) was used to cool the crys- tals during data measurement. Diffraction data for SeMet SaDsbA crystals were measured using X-rays from an RU-H2R-Cr generator with chromium Osmic MaxFlux optics and R-AXIS IV ++ detector (Rigaku Americas, Houston, TX, USA). The crystal-to-detector distance was 150 mm (SaDsbA) or 102 mm (SeMet SaDsbA). Crystals were cryoprotected by soaking for 5 min in 30% PEG 3350 and data were processed using HKL-2000 (Otwinowski & Minor, 1997) .
Results and discussion
A standard vapour-diffusion approach using several commercial crystallization screens failed to generate SaDsbA crystals. However, using a free-interface diffusion crystallization chip we were able to grow small elongated rod-shaped crystals in condition No. 54 of the OptiMix-1 screen, which contains only 25% PEG 3350. This condition was successfully translated to 24-well hanging-drop vapour-diffusion experiments by screening higher concentrations of PEG 3350 and a range of protein:precipitant ratios. Single hexagonal rod-shaped crystals were obtained in 28-30% PEG 3350 in drops that had a protein-to-precipitant ratio of less than 1 (Fig. 1) . We observed that crystals grown from freshly produced protein took twice as long to grow ($10 d) than crystals obtained from protein stored for a few days at 277 K. Mass-spectrometric analysis of dissolved crystals indicated that the protein in the crystals corresponded to a degradation product in which the N-terminal four residues (MASA) and C-terminal seven residues (KLEHHHHHH) were removed. Fortuitously, most of these residues corresponded to non-native residues engineered into the construct.
These SaDsbA crystals diffract to 2.1 Å resolution on the highbrilliance FR-E generator (Fig. 2) . They belong to the hexagonal space group P6 5 or P6 1 , with unit-cell parameters a = b = 72.1, c = 92.1 Å , = = 90, = 120
. Assuming the crystals have one molecule per asymmetric unit, the Matthews coefficient (V M ) is 3.5 Å 3 Da À1 and the solvent content is 64% (Matthews, 1968) ; both are within the usual range for protein crystals. Statistics for the diffraction data are provided in Table 1 .
Initial attempts to solve the structure by molecular replacement using E. coli DsbA as a model and either CNS (Brü nger et al., 1998) or Phaser (Storoni et al., 2004) failed to produce a solution (15% sequence identity). We therefore produced SeMet SaDsbA crystals in order to attempt in-house SAD phasing using Cr K radiation ( = 2.29 Å ). Measuring data at this wavelength doubles the anomalous signal of many elements, including sulfur (Áf 00 = 1.14 e À ) and selenium (Áf 00 = 2.28 e À ), compared with Cu K radiation ( = 1.54 Å ; Áf 00 = 0.56 and 1.14 e À for S and Se, respectively). SeMet SaDsbA crystals diffracted to the corner of the detector (2.44 Å resolution) on the RU-H2R generator, with unit-cell parameters a = b = 72.0, c = 92.4 Å , = = 90, = 120 (Table 1) . However, the signal was weak for Se-SAD/Cr data (anomalous signal d 00 / at 3.5 Å of 0.98), so that the most likely route for phasing will be MAD or SAD data measurement at a synchrotron.
